Silent Myocardial Ischemia: Proceedings of the Symposium on New Drugs and Devices October 15–16, 1987, Philadelphia, Pennsylvania: Developments in Cardiovascular Medicine, cartea 88
Editat de J. Morganroth, E. Neil Mooreen Limba Engleză Paperback – 22 ian 2012
Din seria Developments in Cardiovascular Medicine
- 5%
Preț: 375.20 lei - 5%
Preț: 405.64 lei - 5%
Preț: 382.86 lei - 5%
Preț: 1356.08 lei - 5%
Preț: 365.42 lei - 5%
Preț: 1048.97 lei - 5%
Preț: 1382.39 lei - 5%
Preț: 365.84 lei - 5%
Preț: 357.02 lei - 5%
Preț: 365.81 lei - 5%
Preț: 2034.92 lei - 5%
Preț: 355.87 lei - 5%
Preț: 356.02 lei - 5%
Preț: 357.02 lei - 5%
Preț: 359.75 lei - 5%
Preț: 685.66 lei - 5%
Preț: 1048.97 lei - 5%
Preț: 364.50 lei - 5%
Preț: 362.47 lei - 5%
Preț: 695.99 lei - 5%
Preț: 2034.57 lei - 5%
Preț: 360.88 lei - 5%
Preț: 694.44 lei - 5%
Preț: 364.30 lei - 5%
Preț: 1367.84 lei - 5%
Preț: 691.45 lei - 5%
Preț: 692.85 lei - 5%
Preț: 3060.90 lei - 5%
Preț: 1363.09 lei - 5%
Preț: 687.05 lei - 5%
Preț: 366.54 lei - 5%
Preț: 357.02 lei - 5%
Preț: 404.28 lei - 5%
Preț: 366.69 lei - 5%
Preț: 368.64 lei - 5%
Preț: 2044.40 lei - 5%
Preț: 366.00 lei - 5%
Preț: 1371.17 lei - 5%
Preț: 1359.76 lei - 5%
Preț: 373.89 lei - 5%
Preț: 2783.34 lei - 5%
Preț: 360.33 lei
Preț: 1049.83 lei
Preț vechi: 1105.08 lei
-5%
Puncte Express: 1575
Carte tipărită la comandă
Livrare economică 08-22 iunie
Specificații
ISBN-13: 9781461289807
ISBN-10: 1461289807
Pagini: 260
Ilustrații: XIV, 242 p.
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.37 kg
Ediția:Softcover reprint of the original 1st ed. 1988
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
ISBN-10: 1461289807
Pagini: 260
Ilustrații: XIV, 242 p.
Dimensiuni: 155 x 235 x 14 mm
Greutate: 0.37 kg
Ediția:Softcover reprint of the original 1st ed. 1988
Editura: Springer Us
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I Epidemiology, Pathophysiology, Classification.- 1. Epidemiology and prevalence of silent myocardial ischemia, and prognosis in asymptomatic patients.- 2. Pathophysiology of ischemia: Why are some episodes silent?.- 3. Myocardial ischemia as a useful functional indicator of risk in patients with coronary artery disease.- 4. The diagnostic and prognostic value of exercise ECG and radionuclide markers of ischemia in asymptomatic and symptomatic populations.- 5. An integrated clinical classification for ischemic heart disease: A combined assessment of severity of coronary disease, left ventricular function and myocardial ischemia.- Panel Discussion.- II Detection and Prognosis.- 6. Methods to detect ischemia using ambulatory (Holter) electrocardiography.- 7. The prognostic significance of silent myocardial ischemia during exercise testing.- 8. The role of radionuclide techniques in the evaluation of patients with silent myocardial ischemia.- Panel Discussion.- 9. Longitudinal (natural history) studies of silent myocardial ischemia.- 10. Silent myocardial ischemia and sudden cardiac death.- Panel Discussion.- IV Therapy and FDA Claims.- 11. Antianginal drug therapy for silent myocardial ischemia: Adrenergic blockers and calcium entry blockers.- 12. Therapy for silent ischemia: Nitrates.- 13. What are the FDA requirements to obtain a claim for the indication of silent ischemia?.- Panel Discussion.- V Combination Drug Therapy—FDA Issues.- 14. Combination drug therapy: What studies are required to obtain approval?.- Participant List.